ibrutinib

ibrutinib
Trade Name Imbruvica
Orphan Indication Mantle cell lymphoma
USA Market Approval USA
USA Designation Date 2012-12-03 00:00:00
Sponsor Pharmacyclics, LLC;995 E. Arques Avenue;Sunnyvale, California, 94085